How major US stock indexes fared Wednesday, 6/11/2025
Associated Press
Wall Street’s rally stalled after stocks climbed back within 2% of their all-time high.
The S&P 500 slipped 0.3% Wednesday, marking its first drop in four days. The Dow Jones Industrial Average ended little changed, and the Nasdaq composite lost 0.5%.
The action was stronger in the bond market, where Treasury yields eased after a report showed inflation ticked up by less last month than economists expected. That raised expectations for the Federal Reserve to cut interest rates later this year. Markets didn’t react much to the conclusion of two days of trade talks between the U.S. and China.
On Wednesday:
The S&P 500 fell 16.57 points, or 0.3%, to 6,022.24.
The Dow Jones Industrial Average fell 1.10 points, or less than 0.1%, to 42,865.77.
The Nasdaq composite fell 99.11 points, or 0.5%, to 19,615.88.
The Russell 2000 index of smaller companies fell 8.17 points, or 0.4%, to 2,148.23.
Hospitals could lose millions under Trump plan to alter Medicaid funding formula
Seritage Growth Properties Makes $40 Million Loan Prepayment
Advisor News
- Addressing the ‘menopause tax:’ A guide for advisors with female clients
- Alternative investments in 401(k)s: What advisors must know
- The modern advisor: Merging income, insurance, and investments
- Financial shocks, caregiving gaps and inflation pressures persist
- Americans unprepared for increased longevity
More Advisor NewsAnnuity News
- Globe Life Inc. (NYSE: GL) Making Surprising Moves in Monday Session
- Aspida Life and WealthVest Offer a Powerful New Guaranteed Income Product with the WealthLock® Income Builder
- Lack of digital tools drives wedge between insurers, advisors
- LIMRA: Annuity sales notch 10th consecutive $100B+ quarter
- AIG to sell remaining shares in Corebridge Financial
More Annuity NewsHealth/Employee Benefits News
- Studies from Denise Wolff et al Have Provided New Data on Atopic Dermatitis (AMCP Market Insights: Beyond skin deep on the role of managed care in moderate to severe atopic dermatitis): Skin Diseases and Conditions – Atopic Dermatitis
- New Clinical Trials and Studies Findings from RAND Corporation Described (Benefit design and consumer information: results from a randomized trial): Clinical Research – Clinical Trials and Studies
- School, BOCES healthcare costs up 22%, here’s why
- Healthcare cuts threaten Sullivan's reelection chances in Alaska
- Health insurance marketplace feels growing tremors from GOP cuts
More Health/Employee Benefits NewsLife Insurance News
- Best’s Market Segment Report: AM Best Revises Outlook on Italy’s Life Insurance Segment to Stable From Negative
- Globe Life Inc. (NYSE: GL) Making Surprising Moves in Monday Session
- Dan Scholz to receive NAIFA’s Terry Headley Lifetime Defender Award
- Best’s Special Report: US Property/Casualty and Health Insurers Exceed Cost of Capital; Life Insurers Narrowly Miss
- Aspida Life and WealthVest Offer a Powerful New Guaranteed Income Product with the WealthLock® Income Builder
More Life Insurance News